Friday 6 November 2026 · Edition of the day

Current editionPast editions →

The Skeptic's Daily

The day's biggest stories, taken apart. For each one: what is actually established, what is only asserted, the questions worth asking — and a plausibility score for the central claim, given everything currently known.

Stories
2
Average plausibility
83%
How to read the score
It rates how well the core claim is evidenced — not how important the story is, nor whether it is good or bad news.
01HealthAsia-Pacific

Delhi announces winter pollution plan as experts question its adequacy

Reports support the rollout of seasonal pollution controls, while expert criticism points to problems that temporary restrictions cannot resolve.

BBC reports that Delhi's toxic winter air has returned and that the government has announced a four-month action plan. Other outlets describe measures running between November 1 and February 28, including vehicle restrictions, dust controls and higher parking charges. Experts quoted by The New York Times and The New Indian Express say temporary curbs need broader transport reforms, regional coordination and stronger local enforcement.

What holds up

  • ✓The plan's existence and broad schedule are well supported: BBC describes a four-month plan, while The Times of India reports that individual restrictions run for different periods between November 1 and February 28. The Independent quotes the chief minister's office announcing the November 1 start.
  • ✓The concern about winter air pollution extends beyond BBC's account: The New Indian Express reports deteriorating air quality, and The Times of India's headline reports an air quality index of 261 on November 1. These excerpts do not establish conditions on every subsequent day.
  • ✓Other reporting gives substance to the expert criticism. The New York Times identifies inadequate public transit and poor transportation planning, while The New Indian Express cites experts calling for action on pollution both inside and outside Delhi.

What doesn't yet

  • ?The claim that the plan 'won't be enough' is an expert assessment, not a demonstrated outcome of this winter's rollout. The excerpts provide no current evaluation showing how much pollution the new measures have reduced.
  • ?The dates describe different measures, not necessarily conflicting accounts. The Independent describes restrictions covering November through January but parking increases lasting until February 28; The Times of India explicitly says measures have different durations.
  • ?Several accounts of the rollout rely on government announcements, so repeated descriptions are not separate checks of enforcement. These snippets are not full-article verification, and they do not show whether authorities are consistently applying the rules.

Ask before you share

  • →Which restrictions are actually being enforced, and what evidence shows compliance rather than just an announced start date?
  • →How will officials measure pollution reductions while accounting for weather and pollution arriving from outside Delhi?
  • →What year-round transport and regional pollution measures will accompany the winter restrictions?

Sources & original reporting

  1. [1]BBC News · Published 5 Nov 2026 · bbc.co.uk
  2. [2]Newindianexpress · Published 26 Oct 2026 · newindianexpress.com
  3. [3]The New York Times · Published 1 Nov 2026 · nytimes.com
  4. [4]Independent · Published 1 Nov 2026 · independent.co.uk
  5. [5]Timesofindia Indiatimes · Published 1 Nov 2026 · timesofindia.indiatimes.com
02HealthAsia-Pacific

Singapore biomedical startups turn to China to develop treatments

Reports describe companies building Chinese research and manufacturing ties, but do not establish that those moves have shortened development or produced effective treatments.

CNA reports that Singapore biomedical startups are expanding into China to develop treatments for conditions including cancer and diabetes. Companies including Lion TCR and BetaLife are seeking larger patient populations, hospital partnerships and manufacturing capacity. CNA also highlights regulatory challenges, though the supplied excerpts do not explain specific rule changes or their effects.

What holds up

  • ✓The expansion has concrete company examples behind it. Earlier background reporting from The Business Times describes Lion TCR’s Chinese hospital ties and manufacturing facilities, while ThinkChina reports that BetaLife established joint ventures in Shenzhen and Xiamen in September 2025.
  • ✓CNA’s news excerpt and radio discussion both identify access to patients, clinical partners and manufacturing as reasons for entering China. The Business Times’ background account supports those reasons for Lion TCR, though company statements do not prove that development has actually become faster.

What doesn't yet

  • ?The excerpts provide no trial results, approval records or before-and-after development timelines. Faster development is a stated aim, not a demonstrated outcome; CNA’s warning about evolving regulations also lacks specific examples here.
  • ?Source breadth is limited: the evidence used comes from three original reporting outlets, so other accounts may be missing. CNA’s radio and news coverage are from the same newsroom, and UA News explicitly repeats CNA’s BetaLife reporting rather than supplying a separate check. These excerpts are not full-article verification.

Ask before you share

  • →Which trials have received authorization, started enrolling patients or published results, and have Chinese partnerships measurably shortened their timelines?
  • →Which Chinese regulatory changes affect these companies, and what do they mean for trial oversight, manufacturing standards and eventual approval elsewhere?

Sources & original reporting

  1. [1]CNA · Published 6 Nov 2026 · channelnewsasia.com
  2. [2]Channelnewsasia · Published 3 Nov 2026 · channelnewsasia.com
  3. [3]Ua · Published 6 Nov 2026 · ua.news
  4. [4]Businesstimes · Published 26 Oct 2026 · businesstimes.com.sg
  5. [5]Thinkchina · Published 21 Oct 2026 · thinkchina.sg